TScan Therapeutics, Inc. — Director's Dealing 2021

Jul 16, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TScan Therapeutics, Inc. (TCRX)
CIK: 0001783328
Period of Report: 2021-07-15

Reporting Person: Gruia Gabriela (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-15	Stock Option (right to buy)	$15.00	A	9146	Acquired	2031-07-14	Voting Common Stock (9146)	Direct
2021-07-15	Stock Option (right to buy)	$15.00	A	9146	Acquired	2031-07-14	Voting Common Stock (9146)	Direct

Footnotes

F1: The shares subject to this option will vest in 36 equal monthly installments upon the completion of each month of continuous service to the Issuer after May 4, 2021 .

F2: The shares subject to this option will vest in 12 equal monthly installments upon the completion of each month of continuous service to the Issuer after May 4, 2022.